EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Harnessing RNA Technology to Advance Therapeutic Vaccine Antigens against Chagas Disease

Chiara Mancino, Jeroen Pollet, Assaf Zinger iD, Kathryn M Jones iD, Maria José Villar, Ana Carolina Leao, Rakesh Adhikari, Leroy Versteeg, Rakhi Tyagi Kundu, Ulrich Strych, Federica Giordano, Peter J Hotez und 3 weitere

ACS Applied Materials & Interfaces · 03.04.2024 · 16 (13) · 15832-15846

DOI: 10.1021/acsami.3c18830 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 22.03.2024. Verfasst von Chiara Mancino und 14 weiteren Autor:innen. Beteiligte Einrichtung: Center for Musculoskeletal Regeneration, Houston Methodist Academic Institute, Houston, Texas 77030, United States. Hauptthemen laut MEDLINE: Protozoan Vaccines, Chagas Disease. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, NCRR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protozoan VaccinesChagas DiseaseMiceAnimalsRNATissue DistributionAntigens, ProtozoanRNA, MessengerTechnology

Stichwörter der Autor:innen

Chagas diseasebiodistributionimmunogenicitylipid nanoparticlesmRNA vaccine

Substanzen

RNAProtozoan VaccinesAntigens, ProtozoanRNA, Messenger

Autor:innen und Institutionen

  • Center for Musculoskeletal Regeneration, Houston Methodist Academic Institute, Houston, Texas 77030, United States.
  • Department of Pediatrics, Division of Tropical Medicine, Baylor College of Medicine, Houston, Texas 77030, United States.
  • Texas Children's Hospital Center for Vaccine Development, Houston, Texas 77030, United States.
  • Laboratory for Bioinspired Nano Engineering and Translational Therapeutics, Department of Chemical Engineering, Technion-Israel Institute of Technology, Haifa 3200003, Israel.
  • Cardiovascular Sciences Department, Houston Methodist Academic Institute, Houston, Texas 77030, United States.
  • Neurosurgery Department, Houston Methodist Academic Institute, Houston, Texas 77030, United States.

ORCID-Profile: Assaf Zinger, Kathryn M Jones, Francesca Taraballi

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • NCRR NIH HHS
  • National Cancer Institute
  • National Center for Research Resources
  • National Institute of Allergy and Infectious Diseases
  • Robert J. Kleberg Jr. and Helen C. Kleberg Foundation

Zitieren

APA

Mancino, C., Pollet, J., Zinger, A., Jones, K. M., Villar, M. J., Leao, A. C., Adhikari, R., Versteeg, L., Tyagi Kundu, R., Strych, U., Giordano, F., Hotez, P. J., Bottazzi, M. E., Taraballi, F., & Poveda, C. (2024). Harnessing RNA Technology to Advance Therapeutic Vaccine Antigens against Chagas Disease. ACS Applied Materials & Interfaces, 16(13), 15832-15846. https://doi.org/10.1021/acsami.3c18830

Vancouver

Mancino C, Pollet J, Zinger A, Jones KM, Villar MJ, Leao AC, et al. Harnessing RNA Technology to Advance Therapeutic Vaccine Antigens against Chagas Disease. ACS Applied Materials & Interfaces. 2024;16(13):15832-15846. doi:10.1021/acsami.3c18830

BibTeX
@article{Mancino2024,
  author = {Mancino, Chiara and Pollet, Jeroen and Zinger, Assaf and Jones, Kathryn M and Villar, Maria José and Leao, Ana Carolina and Adhikari, Rakesh and Versteeg, Leroy and Tyagi Kundu, Rakhi and Strych, Ulrich and Giordano, Federica and Hotez, Peter J and Bottazzi, Maria Elena and Taraballi, Francesca and Poveda, Cristina},
  title = {Harnessing RNA Technology to Advance Therapeutic Vaccine Antigens against Chagas Disease},
  journal = {ACS Applied Materials & Interfaces},
  year = {2024},
  volume = {16},
  number = {13},
  pages = {15832--15846},
  doi = {10.1021/acsami.3c18830}
}
Kostenlos starten →